Title
Microgeographical differences of Plasmodium vivax relapse and re-infection in the Peruvian Amazon
Date Issued
01 August 2013
Access level
open access
Resource Type
journal article
Author(s)
Peñataro P.
Brouwer K.
Fasabi M.
Torres S.
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health
University of California at San Diego
Publisher(s)
American Society of Tropical Medicine and Hygiene
Abstract
To determine the magnitude of Plasmodium vivax relapsing malaria in rural Amazonia, we carried out a study in four sites in northeastern Peru. Polymerase chain reaction-restriction fragment length polymorphism of PvMSP- 3a and tandem repeat (TR) markers were compared for their ability to distinguish relapse versus reinfection. Of 1,507 subjects with P. vivax malaria, 354 developed > 1 episode during the study; 97 of 354 (27.5%) were defined as relapse using Pvmsp-3a alone. The addition of TR polymorphism analysis significantly reduced the number of definitively defined relapses to 26 of 354 (7.4%) (P < 0.05). Multivariate logistic regression modeling showed that the probability of having > 1 infection was associated with the following: subjects in Mazan (odds ratio [OR] = 2.56; 95% confidence interval [CI] 1.87, 3.51), 15-44 years of age (OR = 1.49; 95% CI 1.03, 2.15), traveling for job purposes (OR = 1.45; 95%CI 1.03, 2.06), and travel within past month (OR = 1.46; 95% CI 1.0, 2.14). The high discriminatory capacity of the molecular tools shown here is useful for understanding the micro-geography of malaria transmission. Copyright © 2013 by The American Society of Tropical Medicine and Hygiene.
Start page
326
End page
338
Volume
89
Issue
2
Language
English
OCDE Knowledge area
Medicina tropical
Scopus EID
2-s2.0-84881497783
PubMed ID
Source
American Journal of Tropical Medicine and Hygiene
ISSN of the container
00029637
Sponsor(s)
National Institute of Allergy and Infectious Diseases - K24AI068903, R01AI067727, U19AI089681
Fogarty International Center - D43TW007120, R25TW007500
Medical Research Council - MR/K007467/1
National Institutes of Health
Sources of information:
Directorio de Producción Científica
Scopus